Holen Sie sich die Stockscreener-App
29.22
0.72%
0.21
Handel nachbörslich:
29.22
Schlusskurs vom Vortag:
$29.01
Offen:
$29.94
24-Stunden-Volumen:
114.07K
Relative Volume:
1.19
Marktkapitalisierung:
$463.51M
Einnahmen:
$72.30M
Nettoeinkommen (Verlust:
$-6.12M
KGV:
-15.89
EPS:
-1.8384
Netto-Cashflow:
$-41.16M
1W Leistung:
+9.68%
1M Leistung:
+3.36%
6M Leistung:
+19.36%
1J Leistung:
+235.48%
1-Tages-Spanne:
$29.00
$30.18
1-Wochen-Bereich:
$26.66
$30.18
52-Wochen-Spanne:
$7.75
$39.70
Assembly Biosciences Inc Stock (ASMB) Company Profile
Firmenname
Assembly Biosciences Inc
Sektor
Branche
Telefon
(833) 409-4583
Adresse
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Compare ASMB vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
29.22 | 460.18M | 72.30M | -6.12M | -41.16M | -1.8384 |
VRTX
Vertex Pharmaceuticals Inc
|
434.30 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.04 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.25 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.34 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.81 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-08-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-25 | Eingeleitet | Guggenheim | Buy |
| 2024-09-20 | Hochstufung | Jefferies | Hold → Buy |
| 2021-09-13 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-09-02 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | Herabstufung | Jefferies | Buy → Hold |
| 2020-10-19 | Eingeleitet | Truist | Buy |
| 2019-10-16 | Eingeleitet | Mizuho | Buy |
| 2018-11-19 | Eingeleitet | Leerink Partners | Outperform |
| 2018-10-08 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | Eingeleitet | Robert W. Baird | Outperform |
| 2018-04-13 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | Eingeleitet | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | Eingeleitet | Jefferies | Buy |
| 2017-05-30 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Assembly Biosciences Inc Aktie (ASMB) Neueste Nachrichten
Options Flow: Is Assembly Biosciences Inc benefiting from innovation trends2026 Volume Leaders & Growth-Oriented Investment Plans - baoquankhu1.vn
Guggenheim Raises Price Target for ASMB to $43, Maintains Buy Ra - gurufocus.com
Assembly Biosciences (NASDAQ:ASMB) Price Target Raised to $43.00 at Guggenheim - MarketBeat
Guggenheim raises Assembly Biosciences stock price target on herpes drug progress - Investing.com Canada
Understanding the Setup: (ASMB) and Scalable Risk - news.stocktradersdaily.com
ASMB Stock Price, Quote & Chart | ASSEMBLY BIOSCIENCES INC (NASDAQ:ASMB) - ChartMill
Bull Bear: What is the target price for Assembly Biosciences Inc stock2026 Retail Activity & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Assembly Biosciences CMO White sells $5.3k in stock By Investing.com - Investing.com Canada
Assembly Biosciences PFO Bjorkquist sells $8.7k in shares By Investing.com - Investing.com Australia
[Form 4] ASSEMBLY BIOSCIENCES, INC. Insider Trading Activity - Stock Titan
Assembly Biosciences (NASDAQ: ASMB) officer logs RSU grant, tax sell-to-cover - Stock Titan
Assembly Biosciences (ASMB) officer awarded RSUs and sells shares to cover taxes - Stock Titan
Assembly Biosciences (ASMB) CMO awarded 26,000 RSUs vesting through 2030 - stocktitan.net
Assembly Biosciences (ASMB) CEO receives 94,250 RSUs vesting through 2030 - Stock Titan
Resistance Check: Is Assembly Biosciences Inc benefiting from innovation trends2026 WrapUp & Consistent Profit Trade Alerts - baoquankhu1.vn
Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan - tipranks.com
Assembly Biosciences (ASMB) boosts CEO bonus target in 2026 plan - Stock Titan
HC Wainwright Analysts Lower Earnings Estimates for ASMB - Defense World
[EFFECT] ASSEMBLY BIOSCIENCES, INC. SEC Filing - Stock Titan
Wall Street Zen Upgrades Assembly Biosciences (NASDAQ:ASMB) to Strong-Buy - MarketBeat
ETF Watch: Is Assembly Biosciences Inc benefiting from innovation trends2026 Chart Watch & Advanced Technical Signal Analysis - baoquankhu1.vn
Q1 Earnings Estimate for ASMB Issued By HC Wainwright - MarketBeat
Assembly Biosciences (NASDAQ:ASMB) Receives "Buy" Rating from HC Wainwright - MarketBeat
Analyst Patrick R. Trucchio Reiterates Buy Rating for ASMB | ASM - gurufocus.com
Highs Report: Is Assembly Biosciences Inc being accumulated by smart moneyOptions Play & Short-Term Trading Alerts - baoquankhu1.vn
Assembly Bio’s (ASMB) HBV Drug Shows Strong Efficacy in Phase 1b Trial - MSN
Assembly Biosciences (ASMB) Q4 earnings and revenues top estimates - MSN
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial - TipRanks
The Technical Signals Behind (ASMB) That Institutions Follow - news.stocktradersdaily.com
Assembly Biosciences (NASDAQ:ASMB) Upgraded at Wall Street Zen - MarketBeat
Assembly Biosciences (ASMB) Quarterly Profit Of US$22.1 Million Tests Bearish Narratives - simplywall.st
Assembly Biosciences: 'Buy' On HPI Program Opt-In And HDV Candidate Development (ASMB) - Seeking Alpha
Assembly Biosciences, Inc. 2025 Annual Report – Pipeline, Risk Factors, and Financial Outlook - Minichart
Assembly Biosciences Inc (V7B.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Assembly Biosciences (NASDAQ:ASMB) Announces Quarterly Earnings Results, Beats Estimates By $2.99 EPS - MarketBeat
Assembly Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates - Yahoo Finance
Assembly Biosciences Q4 Earnings: Profit Announced, Annual Loss NarrowsNews and Statistics - IndexBox
Assembly Biosciences (ASMB) launches $100M ATM via Jefferies under $400M shelf - Stock Titan
Assembly Biosciences: Fourth Quarter Financial Results Overview - Bitget
Assembly Biosciences: Q4 Earnings Snapshot - MarketScreener
Assembly Biosciences Reports Year-End 2025 Financial Results and Recent Highlights - The Manila Times
Assembly Biosciences 2025 net loss narrows - tradingview.com
Assembly Biosciences (NASDAQ: ASMB) advances antiviral pipeline and expands Gilead deal - Stock Titan
ASMB: 2025 revenue jumped to $72.3M, net loss shrank to $6.1M, and cash reserves rose to $248.1M - TradingView
Assembly Biosciences (Nasdaq: ASMB) slashes 2025 loss as Gilead deal lifts revenue - Stock Titan
Gilead deal hands Assembly Bio $35M as herpes program advances - Stock Titan
Panic Selling: Is Assembly Biosciences Inc being accumulated by smart money2026 Chart Watch & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Risk Analysis: Can Assembly Biosciences Inc stock double in the next yearQuarterly Trade Report & Technical Entry and Exit Alerts - baoquankhu1.vn
Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Assembly Biosciences Inc expected to post a loss of 65 cents a shareEarnings Preview - TradingView
Finanzdaten der Assembly Biosciences Inc-Aktie (ASMB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Assembly Biosciences Inc-Aktie (ASMB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| White Nicole S | Chief Manufacturing Officer |
Mar 30 '26 |
Sale |
26.69 |
197 |
5,258 |
37,477 |
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):